UNODC – April 2017: Recently there has been an increasing number of central nervous system depressants, in particular benzodiazepines, appearing on the NPS market. Of late, a number of such substances have been placed under national control in several countries, including:
- Denmark (clonazolam, deschloroetizolam, diclazepam, flubromazepam, flubromazolam, metizolam, nifoxipam, and pyrazolam)
- Finland (clonazolam, deschloroetizolam, diclazepam, etizolam, flubromazepam, flubromazolam, meclonazepam, nifoxipam, and pyrazolam)
- Republic of Korea (diclazepam)
- Sweden (adinazolam, cloniprazepam, zapizolam, desmethylflunitrazepam, and flunitrazolam)
- Switzerland (clonazolam, deschloroetizolam, diclazepam, etizolam, flubromazepam, flubromazolam, nifoxipam, and pyrazolam)
- Turkey (adinazolam, deschloroetizolam, diclazepam, flubromazepam, flubromazolam, meclonazepam, and pyrazolam).
- United Arab Emirates (diclazepam, etizolam, flubromazepam, and pyrazolam)
For more information please see:
Denmark: Website of the Danish Medicines Agency (Lægemiddelstyrelsen) - (Danish) https://laegemiddelstyrelsen.dk/da/nyheder/2016/tolv-nye-stoffer-paa-listen-over-euforiserende-stoffer/
Finland: Website of the Finnish Government - http://valtioneuvosto.fi/en/article/-/asset_publisher/kaksitoista-uutta-ainetta-huumausaineluetteloon?_101_INSTANCE_3qmUeJgIxZEK_groupId=1271139
Republic of Korea: Webiste of the Korean Food and Drug Administration (식품의약품안전처희망의새시대태극기) - (Korean) http://mfds.go.kr/index.do?mid=676&pageNo=5&seq=33158&sitecode=1&cmd=v
Sweden: Website of the Public Health Agency (Folkhälsomyndigheten) - (Swedish) https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2016/augusti/atta-nya-amnen-klassas-som-narkotika/; (Swedish) https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2017/januari/fem-nya-amnen-klassas-som-narkotika/
Switzerland: Website of the Swiss Government - (German) https://www.admin.ch/opc/de/classified-compilation/20101220/index.html
Turkey: Official Gazette (Resmî Gazete) - (Turkish) http://www.resmigazete.gov.tr/main.aspx?home=http://www.resmigazete.gov.tr/eskiler/2017/01/20170111.htm&main=http://www.resmigazete.gov.tr/eskiler/2017/01/20170111.htm
United Arab Emirates: Website of the Ministry of Health and Prevention - http://www.moh.gov.ae/en/News/Pages/NewsDetail.aspx?itemID=285&sw=1
Vienna, AUSTRIA – March 2017: We are pleased to announce the Fifth International Conference on NPS to be held from 23 to 24 October 2017 at the United Nations in Vienna, Austria. The conference is jointly organised by the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), the World Anti-Doping Agency (WADA), University of Hertfordshire and Sapienza University of Rome.
The first four International Conferences on NPS, held in Budapest (2012; 2015) Swansea (2013) and Rome (2014), were extremely successful events to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level.
The main objectives of this fifth event are to share evidence-based information on NPS and latest trends of misuse; improve the understanding of clinical treatment and management of NPS use; explore policy and legislative responses to NPS; develop innovative prevention measures for vulnerable individuals; identify public health implications of NPS and explore motivations and socio-cultural factors underlying NPS use. To attend this conference please register on the conference webpage. Abstract submissions will open on Wednesday, 1st March 2017 and close on Sunday, 30th April 2017.
Source: Österreich Werbung / Harald Eisenberger
For more information, please see:
V International Conference on Novel Psychoactive Substances (NPS) web page – http://novelpsychoactivesubstances.eu/
Flyer of the V International Conference on Novel Psychoactive Substances (NPS) – http://uni-herts.co.uk/t/7LC-4SIEU-E2MKFUOBC1/cr.aspx
March 2017 – United States: Drug Enforcement Administration to issue a temporary order on para-Fluoroisobutyrfentanyl after fatal intoxications
WASHINGTON, D.C., United States – March 2017: On 23 March, 2017, the United States Drug Enforcement Administration (DEA) notified of the intent to issue a temporary order to schedule the synthetic opioid para-fluoroisobutyrfentanyl (also known as para-fluoroisobutyrylfentanyl) into Schedule I pursuant to the provisions of the Controlled Substances Act (CSA). Substances in Schedule I of the CSA are those that have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. In the United States at least 62 overdose deaths involving the use of para-fluoroisobutyrfentanyl have been confirmed in Maryland in 2016. A recent UNODC publication called “Fentanyl and its analogues - 50 years on” provides further information on the global emergence of fentanyl analogues and their health risks.
For more information, please see:
Federal Register of the United states Government “Schedules of Controlled Substances: Temporary Placement of 4-Fluoroisobutyryl Fentanyl Into Schedule I” – https://www.federalregister.gov/documents/2017/03/23/2017-05728/schedules-of-controlled-substances-temporary-placement-of-4-fluoroisobutyryl-fentanyl-into-schedule?utm_campaign=subscription%20mailing%20list&utm_source=federalregister.gov&utm_medium=email
UNODC Report on “Fentanyl and its analogues - 50 years on” – http://www.unodc.org/documents/scientific/Global_SMART_Update_Vol.17_web.pdf
UNODC EWA news clip on “Fentanyl and its analogues explored in the Global SMART Update 17” – https://www.unodc.org/LSS/Announcement/Details/8c90aa33-25c7-4bd3-b575-59a1ca2e9d35
March 2017 – UNODC: Ten substances "scheduled" at the 60th Session of the Commission on Narcotic Drugs
VIENNA, Austria – March 2017: At its 60th regular session from 13 to 17 March 2017, the Commission on Narcotic Drugs decided to place ten NPS under international control. Following recommendations by the WHO Expert Committee on Drug Dependence, ten substances were added to the relevant schedules of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol and the Convention on Psychotropic Substances of 1971.
Added to the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol
Added to the Convention on Psychotropic Substances of 1971
- 4-Methylethcathinone (4-MEC) - Schedule II
- Ethylone - Schedule II
- Pentedrone (α-Methylaminovalerophenone) - Schedule II
- Ethylphenidate (EPH) - Schedule II
- Methiopropamine (MPA) - Schedule II
- MDMB-CHMICA - Schedule II
- 5F-APINACA (5F-AKB-48) - Schedule II
- XLR-11 - Schedule II
For further information please see:
EWA news clip on substances recommended for scheduling by the WHO Expert Committee on Drug Dependence – https://www.unodc.org/LSS/Announcement/Details/ad6cb51c-fb9f-40fa-ac36-caec490dd501
Detailed information on the thirty-eighth meeting, substance evaluation and previous committees of the WHO ECDD – http://www.who.int/medicines/access/controlled-substances/ecdd/en/
March 2017 – Australia: ”Ecstasy” capsules containing NPS are related to several deaths and severe intoxications in Melbourne
MELBOURNE, Australia – March 2017: Three deaths and at least 20 hospitalisations that occurred in Melbourne from the 15-16 January 2017 have been associated with the use of capsules that were reportedly sold as “ecstasy”, but are suspected to have contained NPS in addition to MDMA. According to the Australian Capital Territory Investigation of Novel Substances (ACTINOS) Group, the contents of these capsules were similar to those analysed in association with another patient who suffered convulsions and required hospitalisation after having used “ecstasy” capsules that were found to contain the phenethylamines fluoroamphetamine (isomer not determined) and 25C-NBOMe. In February 2017, ACTINOS issued an alert warning of the potential harm in using such pink and clear capsules, purchased and consumed as “ecstasy”.
For more information, please see:
Alert from the Australian Capital Territory Investigation of Novel Substances Group – https://www.prism.org.au/wp-content/uploads/2017/02/ultra-alert-pink-capsules-final.pdf
News articles on the mix of NPS sold as MDMA in Melbourne - http://bluelight.org/vb/content/252-25C-NBOMe-4-FA-and-MDMA-mixture; https://energycontrol-international.org/our-international-drug-testing-service-detects-a-dangerous-mixture-from-australia/; http://www.theage.com.au/victoria/police-defend-decision-not-to-warn-public-of-new-drug-after-melbourne-club-deaths-20170206-gu6zf2.html
March 2017 – China: Carfentanil, furanylfentanyl, acrylfentanyl and valerylfentanyl placed under national control
BEIJING, China – February 2017: Effective as of 1 March 2017, China placed the synthetic opioids, carfentanil, furanylfentanyl, acrylfentanyl and valerylfentanyl under national control by adding these substances to the list of substances regulated by the “Administrative Measures on Narcotics and Psychotropic Substances without Medical Use”.